RxDoctor Payments Data

Prakash Deedwania

Cardiovascular Disease · Fresno, CANPI 1467553586

Payments from drug & device makers

$193,103in general payments, 2019–2025

Across 180 payments — averaging $1072.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$76K
  • Sanofi US Services Inc.$35K
  • Boehringer Ingelheim International GmbH$30K
  • Amgen$26K
  • Dr.reddy's Laboratories,inc.$11K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$7K
  • plus $7K from 8 others
$1,402in research payments, 2019–2025

Across 2 payments — averaging $701.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$1K

What the payments were for

  • Consulting fees$16,40034%
  • Speaking & faculty fees$17,55037%
  • Travel & lodging$8,87319%
  • Food & beverage$4,57310%
  • Education$2451%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$193,103 in reported general payments places this provider in the 90th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California

Other cardiovascular disease in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →